COMMUNIQUÉS West-GlobeNewswire
-
First American Equipment Finance renews HFMA Peer Review designation
23/07/2026 -
Aeroflow Health’s Independent Research Identifies Why Mothers Miss Postpartum Care and What Health Plans Can Do About It
23/07/2026 -
Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships
23/07/2026 -
UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026
23/07/2026 -
Guerbet : H1 2026 revenue.
23/07/2026 -
Guerbet : Chiffre d’affaires du 1er semestre 2026.
23/07/2026 -
Invitation to Idorsia's HY 2026 Financial Reporting webcast and conference call
23/07/2026 -
OKYO Pharma Announces Purchase of Shares by Director
23/07/2026 -
Affidea accelerates its UK growth through strategic partnership with LIPS Healthcare
23/07/2026 -
OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
23/07/2026 -
First Choice Healthcare Solutions, Inc. Information on Share Consolidation
23/07/2026 -
Atos achieves CMMC 2.0 Level 2 certification, strengthening readiness for mission-critical and complex defense programs
23/07/2026 -
Serotonin Centers Expands into Greater San Diego with New Del Mar Location
23/07/2026 -
Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
23/07/2026 -
BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches
23/07/2026 -
Revolver Brewing Becomes Revolver Beer and Spirits, Extending the Blood & Honey Brand into Whiskey, Gin and Vodka
23/07/2026 -
Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform
23/07/2026 -
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services
23/07/2026 -
Atsena Therapeutics Receives Orphan Designation from the European Medicines Agency (EMA) for ATSN-101 and ATSN-201
23/07/2026
Pages